Diasorin SpA (MIL:DIA) ROCE %: 5.25% (As of Dec. 2025)


MIL:DIA Diasorin SpA MIL:DIA
69 GF Score
Price €66.48
GF Value €90.07
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Diasorin SpA ROCE %?

Diasorin SpA MIL:DIA +3.13% 69 ROCE % is 5.25% as of Dec. 2025. GuruFocus rates MIL:DIA with a GF Score™ of 69/100 and a GF Value™ of €90.07 (Modestly Undervalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Diasorin SpA's annualized ROCE % for the quarter that ended in Dec. 2025 was 5.25%.

Diasorin SpA  (MIL:DIA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Diasorin SpA ROCE % Related Terms

Diasorin SpA ROCE % Historical Data

* Premium members only.

The historical data trend for Diasorin SpA's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diasorin SpA ROCE % Chart

Diasorin SpA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.99 12.03 7.75 9.12 8.75

Diasorin SpA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.77 11.97 9.86 5.25 9.80
MIL:DIA
69GF Score
Diasorin SpA MIL:DIA
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diasorin SpA ROCE % Calculation

Diasorin SpA's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=236.084/( ( (3304.92 - 275.299) + (2873.163 - 505.794) )/ 2 )
=236.084/( (3029.621+2367.369)/ 2 )
=236.084/2698.495
=8.75 %

Diasorin SpA's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=124.336/( ( (0 - 0) + (2873.163 - 505.794) )/ 1 )
=124.336/( ( 0 + 2367.369 )/ 1 )
=124.336/2367.369
=5.25 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 5.25% mean?
Diasorin SpA (MIL:DIA) has a ROCE % of 5.25% as of Dec. 2025.
Is Diasorin SpA's ROCE % too high?
Diasorin SpA's current ROCE % is 5.25%. Overall, Diasorin SpA has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Diasorin SpA's ROCE % compare to TMO and DHR?
Diasorin SpA's ROCE % of 5.25% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Diagnostics & Research company?
A good ROCE % depends on the Medical Diagnostics & Research industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Diasorin SpA's current ROCE % is 5.25%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diasorin SpA stock overvalued right now?
Based on GuruFocus' analysis, Diasorin SpA (MIL:DIA) is currently considered Modestly Undervalued. The stock's GF Value™ is €90.07, compared to a current price of €66.48 — trading 26.2% below its estimated fair value. The current ROCE % is 5.25%. Diasorin SpA's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Diasorin SpA (MIL:DIA), the current ROCE % is 5.25% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Diasorin SpA (MIL:DIA) Overvalued in 2026?

Based on GuruFocus' analysis, Diasorin SpA stock appears to be undervalued. The current stock price of €66.48 is trading 26.2% below its estimated GF Value™ of €90.07. GuruFocus considers Diasorin SpA to be Modestly Undervalued.

Key valuation signals for MIL:DIA:

  • ROCE %: 5.25%
  • GF Value™: €90.07 vs. price of €66.48 (26.2% below fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the MIL:DIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Diasorin SpA Business Description

Address Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
Diasorin develops and manufactures a broad portfolio of in vitro diagnostics for detecting pathogens and sample contamination from the human body, as well as for use in industrial settings, such as food and water contamination testing. The company operates three segments: immunodiagnostics (69% of sales), molecular diagnostics (16%), and licensed technologies (14%). Diasorin was an important manufacturer of covid tests, which boosted its profits during the pandemic, but this segment's importance has decreased over the years, and in 2025, it accounted for only 1% of total sales.
69GF Score

Get the complete analysis for MIL:DIA

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€66.48
Price
€90.07
GF Value